I am...
All
- All
- HLH/FEL/FHL
- LCH
- Rare Histiocytic Disorders and Other Topics
- RDD
Investigation of Possible Associations of Histocompatibility and/or Tumor Necrosis Factor Types with Susceptibility to LCH or Particular Clinical Manifestations of this Disease
Marilyn Pollack PhD and Kenneth McClain MD, PhD Texas Children’s Hospital – Houston, Texas USA Award Amount:…
Isolation, Identification, and Studies on the Biology of a Transmissible Agent Involved in the Causation of Langerhans Cell Histiocytosis: Implications for Future Treatment Strategies for Disseminated LCH
George Kannourakis PhD Royal Children’s Hospital – Victoria, Australia Award Amount: $72,000
The Role of Apoptosis (Programmed Cell Death) in the Pathogenesis of LCH
Michael Weintraub MD Hadassah-Hebrew University Medical School – Jerusalem, Israel Award Amount: $20,000
Immune Dysregulation in Canine Langerhans Cell Histiocystosis; An Animal Model for the Human Disease
Peter Moore PhD University of California, School of Veterinary Medicine – Davis, California USA Award Amount: $20,000
Generation of Immortalized Cell Lines of Langerhans Cell and Langerhans Cell Histiocytosis Cells
Tony Chu FRCP Royal Post Graduate Medical School – London, United Kingdom Award Amount: $25,000